drugset / Trial / NCT04429308

PDT vs Peels for Treatment of Actinic Keratoses

NCT04429308

Phase 2 Not yet recruiting 60 enrolled Northwestern University
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to to compare photodynamic therapy (PDT) versus the combination of Jessner's solution and 35% trichloroacetic acid (TCA) chemical peels for the treatment of actinic keratoses on upper extremities. This is a randomized clinical trial. Approximately 60 participants with actinic keratoses on both upper arms will be randomized to have one arm receive photodynamic therapy, while the contralateral arm receives Jessner's solution followed immediately by 35% TCA. AKs will be counted before treatment and 2-8 weeks after treatment. This study is a pilot study designed to determine the feasibility of this procedure. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.

Timeline

Start
2026-08
Primary completion
2027-12
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Denatured Ethyl Alcohol Unknown
Comparator Lactic Acid Other / unclassified 14 %
Comparator Resorcinol Small molecule 14 %
Comparator Trichloroacetic acid Small molecule 35 %
Comparator salicylic acid Small molecule 14 %

Indications